PRL and ovarian cancer: Patients with high-level expression of both BRCA2 and PRL in their ovarian cancers have a worse prognosis than those with high expression of BRCA2 or PRL alone in their ovarian cancers (with a HR of 1.43 versus a HR of 1.38 or 1.25 respectively).